Tuyển tập các báo cáo nghiên cứu khoa học ngành y học tạp chí Medical Sciences dành cho các bạn sinh viên ngành y tham khảo đề tài: Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey. | Int. J. Med. Sci. 2010 7 191 International Journal of Medical Sciences 2010 7 4 191-196 Ivyspring International Publisher. All rights reserved Research Paper Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey Davran ỌiẹeklH Hasan Pekdemir2 Nihat Kalay3 Suleyman Binici4 Hakan Altay4 Haldun Muderrisoglu5 1. Baậkent University School of Medicine Department of Cardiology Antalya Turkey 2. Inonu University School of Medicine Department of Cardiology Malatya Turkey 3. Erciyes University School of Medicine Department of Cardiology Kayseri Turkey 4. Baậkent University School of Medicine Department of Cardiology Adana Turkey 5. Baậkent University School of Medicine Department of Cardiology Ankara Turkey H Corresponding author Davran Cicek Baậkent University School of Medicine Department of Cardiology Alanya Antalya Turkey Tel 90 532 3336466 Fax 902425115563. E-mail davrancicek@ Received Accepted Published Abstract Background The efficacy of drug-eluting stents has been shown in randomized trials but some controversy exists regarding which stent sirolimus-eluting or paclitaxel-eluting is more effective in unselected Turkish patients. Therefore we investigated the clinical outcomes of patients who were treated with one type of these drug-eluting stents in the real world. Methods We created a registry and prospectively analyzed data on a consecutive series of all patients who presented to our institution with symptomatic coronary artery disease between February 2005 and March 2007 and who were treated with the sirolimus- or the paclitaxel-eluting stent. The follow-up period after stent implantation was approximately 24 months. The primary end point was a major cardiac event and the secondary end point was stent thrombosis. Informed consent was obtained from all .
